The Latest in Non-Hodgkin Lymphoma

CHMP recommends approving drug to treat FL

May 2, 2016

Childhood cancer risk linked to mother’s birthplace

April 27, 2016

Treatment can produce durable responses in NHL

April 20, 2016

Drug shows early promise for low-grade lymphoma

April 20, 2016

Antibody shows activity against ALL, CLL

April 19, 2016

FDA grants drug accelerated approval for CLL

April 12, 2016

Dual inhibitor shows early promise for DLBCL

April 5, 2016

MicroRNA could be used to treat DLBCL, team says

April 4, 2016

Drug ‘not powerful enough’ to treat CTCL

March 29, 2016

Lenalidomide prolongs PFS, not OS, in rel/ref MCL

March 25, 2016

Drug shows early promise for rel/ref NHL

March 25, 2016

Studies explain how mutations promote lymphoma

March 23, 2016

EMA recommends safety measures for idelalisib

March 22, 2016

Idelalisib trials stopped due to AEs

March 15, 2016

Drug granted orphan designation for DLBCL

March 15, 2016